Historical record - last NADAC effective date: 6/23/2021
Product Information
NICOTINE 4 MG LOZENGE is a generic product labeled by Topco Associates LLC, priced at $0.3434 per EA under NDC 36800053905. Its NADAC has been published 196 times since Oct 4, 2017.
FDA first approved this application on Jul 10, 2009.
Strength
4 mg/1
Manufacturer
Topco Associates LLCNDC
36800053905
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Effective Date
6/23/2021
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA090711FDA Approved
7/10/2009
On Market Since
2/12/2013
Pharmacological Classes
Price Statistics
The NADAC for NICOTINE 4 MG LOZENGE has been published 196 times since Oct 4, 2017, and over the history we have for it it has declined 19.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3434 per EA |
|---|---|
| All-time high | $0.4244 (Oct 11, 2017) |
| All-time low | $0.3389 (Jan 20, 2021) |
| Median price | $0.3679 |
| Average price | $0.3684 |
| Largest weekly change | -14.8% (Oct 18, 2017) |
| Weeks tracked | 196 |
| Tracking since | Oct 4, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-19.1%
Last surveyed Jun 30, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Topco Associates LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicotine Polacrilex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Nicotinic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NICOTINE 4 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for NICOTINE 4 MG LOZENGE, manufactured by Topco Associates LLC, is $0.3434 per EA (NDC 36800053905), effective Jun 30, 2021.
How has the price of NICOTINE 4 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for NICOTINE 4 MG LOZENGE has declined 19.1%. It has been tracked across 196 weekly CMS publications since Oct 4, 2017.
What are the highest and lowest recorded NADAC prices for NICOTINE 4 MG LOZENGE?
Since Oct 4, 2017, the NADAC for NICOTINE 4 MG LOZENGE has ranged from a low of $0.3389 (Jan 20, 2021) to a high of $0.4244 (Oct 11, 2017), with a median of $0.3679 per EA.
Are there cheaper alternatives to NICOTINE 4 MG LOZENGE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NICOTINE 4 MG LOZENGE in a comparable dosage form, but none are currently priced below it.
Who manufactures NICOTINE 4 MG LOZENGE?
NICOTINE 4 MG LOZENGE (NDC 36800053905) is labeled by Topco Associates LLC, and CMS classifies it as a generic product.